Effectdossier · gearchiveerd kwartaal
ARVN
Arvinas, Inc. · Healthcare · Biotechnology
13Gevolgde houders
-1Δ houders
30.77MGehouden aandelen
$226.45MGerapporteerde waarde
+1Nieuwe posities
−2Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders -7.1% ·
aandelenstroom +2.0% ·
netto nieuwe posities -7.7%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | -2 | 34.83M | $289.66M | +6 | −8 |
| Q1 2026 | 87 | +4 | 31.95M | $338.79M | +7 | −3 |
| Q4 2025 | 83 | +1 | 38.40M | $455.50M | +2 | −1 |
| Q3 2025 | 15 | 0 | 28.59M | $243.63M | — | −1 |
| Q2 2025 | 13 | -1 | 30.77M | $226.45M | +1 | −2 |
| Q1 2025 | 11 | +1 | 13.86M | $97.33M | +1 | — |
| Q4 2024 | 10 | -1 | 12.65M | $242.44M | — | −1 |
| Q3 2024 | 10 | 0 | 10.38M | $255.76M | — | — |
| Q2 2024 | 10 | — | 10.17M | $270.82M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 9.39M | — | $69.13M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 9.39M | — | $69.13M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 9.39M | — | $69.13M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passief) | 9.39M | — | $69.13M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 9.39M | — | $69.13M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 6.89M | — | $50.71M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 3.67M | -5.2% | $27.04M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 3.67M | -5.2% | $27.04M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 2.15M | Nieuw | $15.83M | 0.0% | New | 1 | SEC ↗ |
| 25 | Millennium Management ✦ | 1.90M | +44.9% | $13.97M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (passief) | 1.73M | -8.6% | $12.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passief) | 1.59M | +3.1% | $11.67M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passief) | 1.59M | +3.1% | $11.67M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 1.33M | -65.1% | $9.82M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 1.33M | -65.1% | $9.82M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Renaissance Technologies ✦ | 1.21M | +817.9% | $8.94M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 614.46K | +493.2% | $4.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 614.46K | +493.2% | $4.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 614.46K | +493.2% | $4.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 614.46K | +493.2% | $4.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | Marshall Wace ✦ | 166.68K | +713.5% | $1.23M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Marshall Wace ✦ | 166.68K | +713.5% | $1.23M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Norges Bank ✦ (passief) | 105.40K | -89.5% | $775,751 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 8.83K | — | $65,002 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 8.83K | — | $65,002 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| D. E. Shaw & Co. | $15.83M | 0.0% |
Verlaten
| Two Sigma Investments | $900,294 | was 0.0% |
| Wellington Management | $194,680 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 205 houders, 53.97M aandelen, $548.70M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API